Anti-MERS N [9H10]
Invented at A*STAR Accelerate Technologies Pte Ltd
- Datasheet
- References (0)
- Inventor Info
Info
Catalogue Number | 152663 |
Applications | IF WB |
Antigen/Gene or Protein Targets | MERS coronaviurs nucleocapsid protein |
Reactivity | Virus |
Relevance | A novel coronavirus (termed as severe acute respiratory syndrome coronavirus, SARS-CoV) was the cause of a viral outbreak which caused profound disturbances worldwide in 2003. Most recently, another novel coronavirus has achieved successful zoonotic transmission and been named as the Middle East respiratory syndrome coronavirus (MERS-CoV). As of 9 May 2014, a total of 536 people have been infected and the fatality rate is ~27%. As the Nucleocapsid protein (N) protein of coronavirus is an abundant virion protein and highly immunogenic, monoclonal antibody for MERS N will be useful for the detection of the virus especially if the monoclonal antibody can distinguish MERS-CoV from other human coronaviruses. |
Host | Mouse |
Immunogen | GST-MERS N fusion |
Subclass | Inconclusive |
Subclass Notes | Negative results for most recent batch |
Myeloma Used | Sp2/0-Ag14 |
Research Area | Virology |
References
There are 0 reference entries for this reagent.
References: 0 entry
There is no reference for this reagent yet, feel free to use the button below to suggest one.
Add a reference
References: 0 entry
There is no reference for this reagent yet, feel free to use the button below to suggest one.
Add a reference